The role of robotic aortic lymphadenectomy in gynecological cancer: surgical and oncological outcome in a single institution experience

Valerio Gallotta, Alex Federico, Khaled Gaballa, Marco D’Indinosante, Carmine Conte, Maria Teresa Giudice, Angelica Naldini, Claudio Lodoli, Stefano Rotolo, Valeria Gallucci, Lucia Tortorella, Bruno Romanò, Giovanni Scambia, Gabriella Ferrandina

Research output: Contribution to journalArticle

Abstract

Background and Objective: This study aims to investigate the surgical outcomes observed in robotic transperitoneal aortic lymphadenectomy (AL) in gynecological cancer patients. Methods: Retrospective data were collected and analyzed on 71 patients undergoing robotic surgical procedures for gynecological cancers, including transperitoneal AL, between December 2014 and February 2018 at the Catholic University of the Sacred Heart, Rome, Italy. Results: Median age of the sample population was 50 years (range, 26-76 years). The median operative time was 210 minutes (range, 75-480 minutes), the median estimated blood loss was 50 ml (range, 20-300 ml). The number of para-aortic nodes removed was 12 (range, 7-43). In the whole series, 13 patients (18.3%) had at least one metastatic node. Overall, 10 patients (14.1%) experienced any grade early postoperative complications. Three patients experienced more than one complication. Three intraoperative complications occurred with two cases of vascular injury. Conversion to laparotomy was necessary for one patient (1.4%). Conclusions: The present study shows the safety and adequacy of robotic transperitoneal AL as surgical staging step for gynecological cancers in terms of perioperative and postoperative outcomes.

Original languageEnglish
JournalJournal of Surgical Oncology
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Robotics
Lymph Node Excision
Neoplasms
Vascular System Injuries
Intraoperative Complications
Operative Time
Laparotomy
Italy
Safety
Population

Keywords

  • gynecological cancers
  • innovative technologies in surgery
  • minimally invasive surgery
  • personalized medicine
  • robotic surgery

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

The role of robotic aortic lymphadenectomy in gynecological cancer : surgical and oncological outcome in a single institution experience. / Gallotta, Valerio; Federico, Alex; Gaballa, Khaled; D’Indinosante, Marco; Conte, Carmine; Giudice, Maria Teresa; Naldini, Angelica; Lodoli, Claudio; Rotolo, Stefano; Gallucci, Valeria; Tortorella, Lucia; Romanò, Bruno; Scambia, Giovanni; Ferrandina, Gabriella.

In: Journal of Surgical Oncology, 01.01.2018.

Research output: Contribution to journalArticle

Gallotta, Valerio ; Federico, Alex ; Gaballa, Khaled ; D’Indinosante, Marco ; Conte, Carmine ; Giudice, Maria Teresa ; Naldini, Angelica ; Lodoli, Claudio ; Rotolo, Stefano ; Gallucci, Valeria ; Tortorella, Lucia ; Romanò, Bruno ; Scambia, Giovanni ; Ferrandina, Gabriella. / The role of robotic aortic lymphadenectomy in gynecological cancer : surgical and oncological outcome in a single institution experience. In: Journal of Surgical Oncology. 2018.
@article{66484a99ed6b48d3b27dece9f22add4b,
title = "The role of robotic aortic lymphadenectomy in gynecological cancer: surgical and oncological outcome in a single institution experience",
abstract = "Background and Objective: This study aims to investigate the surgical outcomes observed in robotic transperitoneal aortic lymphadenectomy (AL) in gynecological cancer patients. Methods: Retrospective data were collected and analyzed on 71 patients undergoing robotic surgical procedures for gynecological cancers, including transperitoneal AL, between December 2014 and February 2018 at the Catholic University of the Sacred Heart, Rome, Italy. Results: Median age of the sample population was 50 years (range, 26-76 years). The median operative time was 210 minutes (range, 75-480 minutes), the median estimated blood loss was 50 ml (range, 20-300 ml). The number of para-aortic nodes removed was 12 (range, 7-43). In the whole series, 13 patients (18.3{\%}) had at least one metastatic node. Overall, 10 patients (14.1{\%}) experienced any grade early postoperative complications. Three patients experienced more than one complication. Three intraoperative complications occurred with two cases of vascular injury. Conversion to laparotomy was necessary for one patient (1.4{\%}). Conclusions: The present study shows the safety and adequacy of robotic transperitoneal AL as surgical staging step for gynecological cancers in terms of perioperative and postoperative outcomes.",
keywords = "gynecological cancers, innovative technologies in surgery, minimally invasive surgery, personalized medicine, robotic surgery",
author = "Valerio Gallotta and Alex Federico and Khaled Gaballa and Marco D’Indinosante and Carmine Conte and Giudice, {Maria Teresa} and Angelica Naldini and Claudio Lodoli and Stefano Rotolo and Valeria Gallucci and Lucia Tortorella and Bruno Roman{\`o} and Giovanni Scambia and Gabriella Ferrandina",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/jso.25335",
language = "English",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - The role of robotic aortic lymphadenectomy in gynecological cancer

T2 - surgical and oncological outcome in a single institution experience

AU - Gallotta, Valerio

AU - Federico, Alex

AU - Gaballa, Khaled

AU - D’Indinosante, Marco

AU - Conte, Carmine

AU - Giudice, Maria Teresa

AU - Naldini, Angelica

AU - Lodoli, Claudio

AU - Rotolo, Stefano

AU - Gallucci, Valeria

AU - Tortorella, Lucia

AU - Romanò, Bruno

AU - Scambia, Giovanni

AU - Ferrandina, Gabriella

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background and Objective: This study aims to investigate the surgical outcomes observed in robotic transperitoneal aortic lymphadenectomy (AL) in gynecological cancer patients. Methods: Retrospective data were collected and analyzed on 71 patients undergoing robotic surgical procedures for gynecological cancers, including transperitoneal AL, between December 2014 and February 2018 at the Catholic University of the Sacred Heart, Rome, Italy. Results: Median age of the sample population was 50 years (range, 26-76 years). The median operative time was 210 minutes (range, 75-480 minutes), the median estimated blood loss was 50 ml (range, 20-300 ml). The number of para-aortic nodes removed was 12 (range, 7-43). In the whole series, 13 patients (18.3%) had at least one metastatic node. Overall, 10 patients (14.1%) experienced any grade early postoperative complications. Three patients experienced more than one complication. Three intraoperative complications occurred with two cases of vascular injury. Conversion to laparotomy was necessary for one patient (1.4%). Conclusions: The present study shows the safety and adequacy of robotic transperitoneal AL as surgical staging step for gynecological cancers in terms of perioperative and postoperative outcomes.

AB - Background and Objective: This study aims to investigate the surgical outcomes observed in robotic transperitoneal aortic lymphadenectomy (AL) in gynecological cancer patients. Methods: Retrospective data were collected and analyzed on 71 patients undergoing robotic surgical procedures for gynecological cancers, including transperitoneal AL, between December 2014 and February 2018 at the Catholic University of the Sacred Heart, Rome, Italy. Results: Median age of the sample population was 50 years (range, 26-76 years). The median operative time was 210 minutes (range, 75-480 minutes), the median estimated blood loss was 50 ml (range, 20-300 ml). The number of para-aortic nodes removed was 12 (range, 7-43). In the whole series, 13 patients (18.3%) had at least one metastatic node. Overall, 10 patients (14.1%) experienced any grade early postoperative complications. Three patients experienced more than one complication. Three intraoperative complications occurred with two cases of vascular injury. Conversion to laparotomy was necessary for one patient (1.4%). Conclusions: The present study shows the safety and adequacy of robotic transperitoneal AL as surgical staging step for gynecological cancers in terms of perioperative and postoperative outcomes.

KW - gynecological cancers

KW - innovative technologies in surgery

KW - minimally invasive surgery

KW - personalized medicine

KW - robotic surgery

UR - http://www.scopus.com/inward/record.url?scp=85058620754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058620754&partnerID=8YFLogxK

U2 - 10.1002/jso.25335

DO - 10.1002/jso.25335

M3 - Article

AN - SCOPUS:85058620754

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

ER -